Home > Drugs A-Z > Zantac Maximum Strength 150 Cool Mint

Zantac Maximum Strength 150 Cool Mint (Boehringer Ingelheim Pharmaceuticals Inc.)

Available Formats

Dosage Form Package Information Links
TABLET, COATED 1 BOTTLE in 1 CARTON (0597-0120-87) > 85 TABLET, COATED in 1 BOTTLE Label Information
TABLET, COATED 80 POUCH in 1 CARTON (0597-0120-82) > 1 TABLET, COATED in 1 POUCH Label Information
TABLET, COATED 1 BOTTLE in 1 CARTON (0597-0120-68) > 65 TABLET, COATED in 1 BOTTLE Label Information
TABLET, COATED 80 POUCH in 1 CARTON (0597-0120-80) > 1 TABLET, COATED in 1 POUCH Label Information
TABLET, COATED 4 BLISTER PACK in 1 CARTON (0597-0120-09) > 8 TABLET, COATED in 1 BLISTER PACK Label Information
TABLET, COATED 1 BOTTLE in 1 CARTON (0597-0120-50) > 50 TABLET, COATED in 1 BOTTLE Label Information
TABLET, COATED 1 BLISTER PACK in 1 CARTON (0597-0120-06) > 3 TABLET, COATED in 1 BLISTER PACK Label Information
TABLET, COATED 3 BLISTER PACK in 1 CARTON (0597-0120-24) > 8 TABLET, COATED in 1 BLISTER PACK Label Information
TABLET, COATED 1 BLISTER PACK in 1 CARTON (0597-0120-38) > 8 TABLET, COATED in 1 BLISTER PACK Label Information
TABLET, COATED 1 TABLET, COATED in 1 POUCH (0597-0120-08) Label Information

Complete Zantac Maximum Strength 150 Cool Mint Information

  • Drug Facts

    Active ingredient (in each tablet) Purpose
    Ranitidine 150 mg (as ranitidine hydrochloride 168 mg).............................................................................................................................. Acid reducer

  • Uses

    • relieves heartburn associated with acid indigestion and sour stomach
    • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

  • Warnings

    Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

    Do not use

    • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
    • with other acid reducers
    • if you have kidney disease, except under the advice and supervision of a doctor

  • Ask a doctor before use if you have

    • had heartburn over 3 months. This may be a sign of a more serious condition.
    • heartburn with lightheadedness, sweating or dizziness
    • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
    • frequent chest pain
    • frequent wheezing, particularly with heartburn
    • unexplained weight loss
    • nausea or vomiting
    • stomach pain

  • Stop use and ask a doctor if

    • your heartburn continues or worsens
    • you need to take this product for more than 14 days

    If pregnant or breast-feeding, ask a health professional before use.
    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


  • Directions

    • adults and children 12 years and over:
      • to relieve symptoms, swallow 1 tablet with a glass of water
      • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
      • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
      • do not chew tablet
    • children under 12 years: ask a doctor

  • Other information

    • do not use if printed foil under bottle cap is open or torn (bottles)
    • do not use if individual blister unit is open or torn (blisters)
    • do not use if individual foil packet is open or torn (pouch)
    • store at 20-25ºC (68-77ºF)
    • avoid excessive heat or humidity
    • this product is sodium and sugar free

  • INACTIVE INGREDIENT

    Inactive ingredients FD&C Blue No.1, flavors, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sucralose, titanium dioxide


  • QUESTIONS

    Questions? call 1-888-285-9159 (English/Spanish) M – F, 8:30 – 5 EST, or visit www.zantacotc.com

    Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

    Distributed by: Boehringer Ingelheim (BI) Consumer Health Care Products
    Division of BI Pharmaceuticals, Inc., Ridgefield, CT 06877
    © 2016, BI Pharmaceuticals, Inc. All rights reserved.
    Product of Spain. Manufactured in Mexico.


  • PRINCIPAL DISPLAY PANEL

    Zantac 150 mg Cool Mint - 24 Count Carton

    zantac-150-cool-mint-24ct

  • PRINCIPAL DISPLAY PANEL

    Zantac 150 mg Cool Mint - 65 Count Carton

    zantac-150-cool-mint-65ct

  • INGREDIENTS AND APPEARANCE
    ZANTAC MAXIMUM STRENGTH 150 COOL MINT 
    ranitidine tablet, coated
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:0597-0120
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ranitidine hydrochloride (UNII: BK76465IHM) (ranitidine - UNII:884KT10YB7) ranitidine 150 mg
    Inactive Ingredients
    Ingredient Name Strength
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    hypromelloses (UNII: 3NXW29V3WO)  
    magnesium stearate (UNII: 70097M6I30)  
    cellulose, microcrystalline (UNII: OP1R32D61U)  
    polyethylene glycols (UNII: 3WJQ0SDW1A)  
    polysorbate 80 (UNII: 6OZP39ZG8H)  
    sucralose (UNII: 96K6UQ3ZD4)  
    titanium dioxide (UNII: 15FIX9V2JP)  
    Product Characteristics
    Color BLUE Score no score
    Shape PENTAGON (5 sided) Size 4mm
    Flavor MINT Imprint Code Z;150
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:0597-0120-06 1 in 1 CARTON
    1 3 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2 NDC:0597-0120-08 1 in 1 POUCH; Type 0: Not a Combination Product
    3 NDC:0597-0120-09 4 in 1 CARTON
    3 8 in 1 BLISTER PACK; Type 0: Not a Combination Product
    4 NDC:0597-0120-24 3 in 1 CARTON
    4 8 in 1 BLISTER PACK; Type 0: Not a Combination Product
    5 NDC:0597-0120-38 1 in 1 CARTON
    5 8 in 1 BLISTER PACK; Type 0: Not a Combination Product
    6 NDC:0597-0120-50 1 in 1 CARTON
    6 50 in 1 BOTTLE; Type 0: Not a Combination Product
    7 NDC:0597-0120-68 1 in 1 CARTON
    7 65 in 1 BOTTLE; Type 0: Not a Combination Product
    8 NDC:0597-0120-80 80 in 1 CARTON
    8 1 in 1 POUCH; Type 0: Not a Combination Product
    9 NDC:0597-0120-82 80 in 1 CARTON
    9 1 in 1 POUCH; Type 0: Not a Combination Product
    10 NDC:0597-0120-87 1 in 1 CARTON
    10 85 in 1 BOTTLE; Type 0: Not a Combination Product
    11 NDC:0597-0120-78 1 in 1 CARTON
    11 78 in 1 BOTTLE; Type 0: Not a Combination Product
    12 NDC:0597-0120-76 2 in 1 CARTON
    12 8 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    NDA NDA021698 12/21/2006
    Labeler - Boehringer Ingelheim Pharmaceuticals Inc. (603175944)
    Registrant - Boehringer Ingelheim Pharmaceuticals Inc. (603175944)
    Establishment
    Name Address ID/FEI Business Operations
    Patheon Manufacturing Services LLC 079415560 MANUFACTURE(0597-0120)
    Establishment
    Name Address ID/FEI Business Operations
    Boehringer Ingelheim Promeco S.A de C.V. 812579472 LABEL(0597-0120) , PACK(0597-0120) , MANUFACTURE(0597-0120) , ANALYSIS(0597-0120)